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Abstract
Neurogenesis is a complex process leading to the generation of neuronal networks and glial cell types from stem cells or
intermediate progenitors. Mapping subcellular and molecular changes accompanying the switch from proliferation to differen-
tiation is vital for developing therapeutic targets for neurological diseases. Neuronal (N-type) and glial (S-type) phenotypes
within the SH-SY5Y neuroblastoma cell line have distinct differentiation responses to 9-cis-retinoic acid (9cRA). In both cell
phenotypes, these were accompanied at the single cell level by an uncoupling of Ca2+ store release from store-operated Ca2+ entry
(SOCE), mediated by changes in the expression of calcium release-activated calcium pore proteins. This remodelling of calcium
signalling was moderated by the predominant cell phenotype within the population. N- and S-type cells differed markedly in their
phenotypic stability after withdrawal of the differentiation inducer, with the phenotypic stability of S-type cells, both morpho-
logically and with respect to SOCE properties, in marked contrast to the lability of the N-type phenotype. Furthermore, the SOCE
response of I-type cells, a presumed precursor to both N- and S-type cells, varied markedly in different cell environments. These
results demonstrate the unique biology of neuronal and glial derivatives of common precursors and suggest that direct or indirect
interactions between cell types are vital components of neurogenesis that need to be considered in experimental models.
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Introduction
Mapping subcellular andmolecular changes that accompany the
cellular switch from proliferation to differentiation is vital for
developing therapeutic targets for neurological diseases.
Neurogenesis in the central and peripheral nervous systems is
a complex process, involving the generation of diverse networks
of neuronal cells and their supporting glial cell types from neu-
ronal stem cells or from intermediate progenitor cells (IPCs;
[1]). Many studies of neuronal differentiation in vitro have used
human neuroblastoma cell lines as models of human disease,
and the SH-SY5Y cell line has attracted particular use as a
model for Parkinson’s disease [2]. Whilst it is possible, with
special manipulation, to obtain homogenous populations of neu-
ronal SH-SY5Y cells [3], this cell line is of particular interest
because both neuronal and glial-like cells can be identified with-
in SH-SY5Y cultures. The cell line represents a powerful ap-
proach for studying the processes of neuronal and glial lineage
development from the putative IPCs or I-type SH-SY5Y cells
which can be identified within SH-SY5Y cell populations.
At least three distinct phenotypes can be recognised in the
SH-SY5Y cell line. N-type cells (Fig. 1a) are immature neu-
ronal precursors which express neuronal cell markers such as
neurofilament protein [4], dopamine β-hydroxylase [4, 5] and
β-tubulin III [6]. N-type cells differentiate towards a neuronal
lineage in response to compounds such as 9-cis-retinoic acid
(9cRA) [6]. Substrate adherent or glial-like S-type cells
(Fig. 1g) express vimentin [6], fibronectin and tyrosinase [4,
7], markers characteristic of non-neuronal stromal or glial
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cells. S-type cells respond to 9cRA by becoming more
epithelial-like with a flattened morphology [6]. I-type cells
exhibit characteristics of both N- and S-type cells and may
represent a multi-potent progenitor population [4, 7].
Phenotypic interconversion can occur between N-type and
S-type cells [4, 5].
Intracellular free Ca2+ is a ubiquitous signalling ion, regu-
lated by release from endoplasmic reticulum (ER) stores and
uptake from the cellular milieu, and plays a vital role in cell
differentiation [8–11]. Store-operated Ca2+ entry (SOCE) is
mediated by STIM1, a Ca2+-binding protein that senses endo-
plasmic reticulum (ER) Ca2+ store depletion [12–14], and
Orai1, which forms the pore of Ca2+ release-activated Ca2+
(CRAC) channels [12–17]. STIM1 oligomerises and forms
puncta with the plasma membrane (PM) after ER Ca2+ store
depletion and directly gates Orai1 to trigger cytosolic influx of
extracellular Ca2+ [12, 15, 18]. This process is crucial for
replenishing depleted intracellular ER Ca2+ stores and
prolonging the Ca2+ response for downstream signalling [9,
19–21]. We have previously shown that 9cRA-induced
differentiation of SH-SY5Y neuroblastoma cell populations
induces an uncoupling of SOCE from ER Ca2+ store release
[6, 22] coincidingwith STIM1 andOrai1 down-regulation [6].
Although evidence suggested that S-type SH-SY5Y cells do
not show an uncoupling of these two processes [6], this has
not been investigated at the single-cell level. This study tests
the hypothesis that N- and S-type cells differ in their differen-
tiation response with respect to Ca2+ release and SOCE, and
investigates the cellular context of such responses with respect
to potential modulating effects of different cell phenotypes.
Material and Methods
Materials
SH-SY5Y cells were from Professor R. Ross (Fordham
University, NY, USA). FluoroSave, fura-2/AM and
thapsigargin were from Calbiochem (Darmstadt, Germany);
all other chemicals were from Sigma-Aldrich (Dorset, UK)
unless stated otherwise.
Cell Culture and Establishment of N-Type and S-Type
Predominant Populations
SH-SY5Y and S-type enriched populations were cultured in
Dulbecco’s Modified Eagle Medium (DMEM)/F12:1 with
GlutaMAX™ (Life Technologies, Paisley, UK), supplement-
ed with foetal calf serum (10% v/v), penicillin (100 IU ml−1)
and streptomycin (100 IU ml−1), and incubated at 37 °C in a
humidified 5% CO2 atmosphere. Cells were passaged once a
week with 0.02% ethylenediaminetetraacetic acid (EDTA)
when approximately 90% confluent andwere not used beyond
passage 25. SH-SY5Y populations consist predominantly of
N-type cells and were used in experiments to represent N-type
predominant populations. S-type predominant populations
were established by means of enrichment for substrate adher-
ence through washing in PBS and gentle agitation to remove
less adherent N-type cells (Bell 2013). S-type enrichment was
repeated four times when cells were ~ 80% confluent.
Differentiation and Cell Phenotype
Cells were seeded at least 24 h before treatment to allow
sufficient cell adhesion and were subsequently treated with
1 μM 9cRA in complete media to induce differentiation or
with 0.01% EtOH as a control treatment for proliferating cells.
Differentiation and control media were replaced every 2 days
for up to 7 days. After 7 days, treatment was withdrawn and
cells were grown in complete media alone for a further 5 days.
Proliferating and differentiating N-type predominant (PN and
Fig. 1 Differentiation of N-type-enriched and S-type-enriched popula-
tions. N-type (a) or S-type enriched populations (g) were treated for up
to 7 days with 1 μM 9cRA to induce differentiation (c, i) or an equivalent
volume of EtOH for proliferating controls (b, h) after which treatment
was withdrawn and cells were grown for a further 5 days (WD). Scale
bars (phase-contrast images) represent 50 μm. Cells proliferating within
N-type-enriched populations had short, neurite-like processes (a, arrows)
and often grew in aggregates. Differentiating N-type-enriched popula-
tions contained cells with elongated neurites (c, day 7), whereas after
washout cultures they were similar to proliferating cultures (b, c, WD).
Within proliferating S-type-enriched populations, cells had abundant cy-
toplasm and a flattened morphology (g, arrows). Cells within differenti-
ating S-type populations frequently exhibited a flattened morphology
with spread cell margins (i, day 7; arrows), retained after washout (i,
WD). Over the treatment time course, there was a significant increase in
proportion of differentiated cells in N-type-enriched populations treated
with 9cRA (d, 488–1192 cells per time point) compared to proliferating
populations (d, 398–1084 cells per time point; linear model, effect of time
F1,10 = 24.3, P < 0.001; differentiation F1,10 = 247.6, P < 0.0001; interac-
tion F1,10 = 17.6, P < 0.002). After washout (WD), the proportion of dif-
ferentiated cells returned to baseline (d). For cells in S-enriched popula-
tions, there was a significant effect of 9cRA (j, 399–543 cells per time
point) in increasing cell diameter compared to proliferating cells (j, 315–
678 cells per time point; differentiation effect, F4,7171 = 468.8, P < 0.001)
which remained after washout. In N-type-enriched cultures, Bcl-2 expres-
sion (normalised to β-actin) increased after treatment with 9cRA (e, ex-
ample blot in f), but increased to a lesser extent and only after 6–7 days in
proliferating cultures (e; differentiation effect, linear mixed-effect analy-
sis: P < 0.001). After washout, Bcl-2 expression was similar in differen-
tiating and proliferating cultures (e; f: example blot of a single experiment
[filter was torn at day 5 PN track during processing and image re-joined]).
For S-type-enriched populations, there was a small but significant differ-
ence in Bcl-2 expression between proliferating and differentiating popu-
lations (k; example blot in l) over the treatment time course (effect of
differentiation: P = 0.05), and a significant difference between proliferat-
ing and differentiating cells over time (interaction: P = 0.004). All error
bars are ± SEM
R
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DN respectively) and S-type predominant (PS and DS respec-
tively) populations were used for experiments from days 1 to 7
of treatment and after treatment withdrawal (WD).
Proliferating N-type cells were identified on the basis of short,
branched neurite-like processes arising from the small, round-
ed or slightly elongated cell bodies [6]. S-type cells had a
flattened, spread morphology with no neurite-like processes,
morphological criteria consistent (CLW, CPFR, TRC, unpub-
lished data) with expression of the S-type markers vimentin
and beta-tubulin III [6]. I-type cells were identified by a flat-
tened morphology but with one or more neurite-like process-
es. Phase-contrast and differential interference contrast (DIC)
images were used with MetaMorph software to measure cell
differentiation after treatment. To measure differentiation of
N-type cells, the total number of N-type cells and total number
of differentiated cells, defined as possessing one or more
neurites ≥ 50 μm in length, were counted manually. We have
observed that S-type cells increase in diameter after 9cRA
treatment and have used this as an objective criterion of dif-
ferentiation in response to 9cRA.
Immunofluorescence
Cells grown on glass coverslips were fixed with PFA (4% w/
v), permeabilised using Triton X-100 (0.1% v/v) and blocked
with bovine serum albumin (BSA, 5% w/v). Cells were incu-
bated for 2 h at 4 °C with anti-STIM1 (1/50, BD Biosciences,
USA) then incubated for 1 h at 4 °C with anti-mouse conju-
gate to FITC (Santa Cruz, USA). Coverslips were mounted
onto glass slides with FluorSave Reagent. Images were cap-
tured using an Axiovert 200M confocal microscope (Carl
Zeiss Ltd.) using a 63× oil immersion objective with 488-
nm excitation light from an argon laser. Confocal images were
acquired with the pinhole set at 1 Airy unit, 12-bit data depth,
scan speed of 9 and mean of eight acquisitions. Images and
quantification were obtained using LSM Image Browser
(Zeiss) and ImageJ [23] software.
Western Blotting
Cells were lysed in situ at 4 °C with lysis buffer containing
10% (v/v) Triton X-100, 2 mM Tris (pH 7.6), 1.28 mM su-
crose, 1 mM EGTA (pH 8), 1 mM EDTA (pH 8) and protease
inhibitor cocktail (Roche Diagnostics, Indianapolis, USA)
then scraped from the plate and transferred to microcentrifuge
tubes. Lysates were homogenised using a 20-G needle and
centrifuged at 12,000 rpm for 10 min at 4 °C. Bradford assays
were used to determine protein concentration in cell samples
with BSA as a protein standard. The absorbance of samples
with Protein Assay Dye Reagent Concentrate (Bio-Rad,
Hertfordshire, UK) added was measured at 595 nm. Gel
electrophoresis through NuPAGE 10% Bis-Tris gels
(Invitrogen, California, USA) was used to separate total pro-
tein (20–40 μg) in sodium dodecyl sulphate (SDS) sample
buffer (2% w/v SDS, 5% v/v 2-mercaptoethanol, 10% w/v
glycerol and bromophenol blue in 60 mM Tris, pH 6.8) by
reference to Precision Plus Protein Dual Color Standards (Bio-
Rad). Separated proteins were transferred to a nitrocellulose
membrane (Bio-Rad) and blocked for 1 h at RT (5% w/vmilk,
0.02% v/v Triton X-100 in PBS). Blots were incubated with
primary antibodies in incubation buffer (2.5% w/v milk in
PBS) overnight at 4 °C. Primary antibodies included anti-β-
actin (1/10,000, Abcam, UK), anti-Bcl-2 (1/200, Santa Cruz,
USA), anti-STIM1 (1/200, BD Biosciences) and anti-Orai1
(1/200). Membranes were washed in a washing buffer (2.5%
w/v milk, 0.2% v/v Triton X-100 in PBS) and incubated with
horseradish peroxidase-conjugated mouse or rabbit secondary
antibodies (1/5000, Dako, Denmark) for 1 h at RT. Enhanced
chemiluminescence (1.25 mM luminol in 0.1 M Tris-HCL
(pH 8.5), 0.09 mM p-coumaric acid and 0.09% v/v hydrogen
peroxide) was used to detect immunoreactive bands on
Hyperfilm™ (GE Healthcare, Amersham, Buckinghamshire,
UK). Samples loaded on gels were loaded in a time-course
order, alternating, proliferating and differentiating cell sam-
ples, and analysed with respect to treatment effects using den-
sitometry of bands (ImageJ software [23]) normalised to β-
actin expression as the loading control. Data consisted of three
to six complete 7-day time-course replicates, with data for a
subsequent washout condition (analysed at day 12) and addi-
tional data from separate experiments at day 7.
CRAC Channel Inhibition
Cells were treated with varying concentrations (0.1–20 μM)
o f t h e CRAC c h a n n e l i n h i b i t o r N - [ 4 - [ 3 , 5 -
bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-4-methyl-
1,2,3-thiadiazole-5-carboxamide (BTP2) and used for experi-
ments after 24 h of treatment.
Single-Cell Ca2+ Add-Back Experiments
Cells were washed with Krebs buffer (10 mM glucose,
4.2 mM NaHCO3, 1.2 mM MgSO4, 1.2 mM KH2PO4,
4.7 mM KCl, 118 mM NaCl, 2 mM CaCl2, 200 μM sulfinpy-
razone, 10 mM HEPES, pH 7.4) and loaded with the Ca2+-
sensitive fluorescent dye fura-2/AM (3 μM) for 45 min at RT.
After loading, cells were incubated in Krebs buffer for a fur-
ther 30 min to allow de-esterification of fura-2/AM. Cells
were washed in Ca2+-free Krebs buffer and mounted into a
coverslip holder (custom-made), producing a chamber into
which Ca2+-free Krebs buffer was added. Ratiometric imaging
was utilised through detection of fura-2 fluorescence at an
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excitation wavelength of 340 nm (300 ms exposure) and
380 nm (80 ms exposure) and an emission wavelength of
510 nm using a Nikon Eclipse TE300 microscope. Images
were obtained with a charge-coupled device camera
(Micromax, Sony Interline Chip, Princeton Instruments,
Trenton, NJ) using a 20× objective.
After establishment of a steady baseline, 200 nM
thapsigargin (TG) was added to induce ER Ca2+ store deple-
t ion fol lowed by 2 mM CaCl2 to induce SOCE.
Measurements of changes in fluorescence ratio (FR) in single
cells were recorded with MetaFluor software (Universal
Imaging, Marlow, UK) and used as a representation of
[Ca2+]i. Data were recorded inMicrosoft Excel for each region
of interest, and individual single-cell recordings were assigned
to a morphological phenotype (N-type, S-type or I-type). The
area under the curve (AUC), peak height (PH), rate of rise and
rate of decline for the initial 300 s from the peak height for TG
and CaCl2 responses were calculated using VBA-coded func-
tions in a Microsoft Excel template spread sheet custom built
by Dr. Graham Scholefield. AUC and PH basal Ca2+ entry,
determined by the addition of DMSO followed by CaCl2,
were subtracted from all experimental data.
Statistical Analysis
Data are presented as means ± S.E.M. Statistical analysis
was carried out using R version 3.1.2 [24] and the pack-
ages ‘effects’, ‘PerformanceAnalytics’, ‘car’, ‘lme4’,
‘MASS’, ‘afex’, ‘doParallel’ and ‘phia’. SOCE ‘area under
calcium-entry curve’ (AUC) data for single cells were
analysed after subtraction of the mean background AUC
for cells without prior thapsigargin treatment per experi-
ment, per cell type and per population (and per time point
for time-course data). Negative values were regarded as
zero, and all background-subtracted data were transformed
by adding 0.001 to avoid zeros. Box-cox transformation
was used to normalise the data where appropriate, and
quantile-quantile plots were used to assess data normalisa-
tion. Linear mixed-effect models with experiment and cov-
erslip within experiment as random effects were used
(package ‘lme4’) to test the effects of cell population (n-
enriched or s-enriched), differentiation (9cRA treatment)
and time, on the calcium release (thapsigargin treatment)
and entry responses (SOCE) of single cells. Since lme4
does not explicitly provide main or interaction effect prob-
abilities, these were estimated using the function ‘mixed’
in the package ‘afex’. Interaction contrasts were estimated
using the package ‘phia’. For protein expression and cell
morphology data, relationships between data points are
indicated on graphs using first- or second-order linear
functions (protein expression) and logistic growth curves
(morphology; package ‘drc’). For linear models of differ-
entiation, responses with time after 9cRA treatment and
population enrichment type were included as additive ef-
fects or interactions on the basis of model selection guided
by ANOVA and Akaike’s information criterion (AIC). For
Western blot densitometry data, first- or second-order
mixed-effects linear models, in which ‘experiment’ was
included as a random effect, were used to test the signifi-
cance of differentiation and time effects, as above. The
level of significance is indicated in figures as P < 0.05*,
P < 0.01** and P < 0.001***; ns means not significant.
Results
Ca2+ store release and add-back experiments were performed
on N-type-enriched and S-type-enriched SH-SY5Y popula-
tions to measure changes in SOCE activity of single cells in
response to 9cRA-induced differentiation. The N-type-
enriched and S-type-enriched populations both contained N-
type, S-type and I-type cells; studying the Ca2+ signal changes
with differentiation at a single-cell level allows characterisa-
tion of phenotype-specific Ca2+ responses and how these are
affected by differentiation in different cellular contexts. N-
type-enriched populations consisted primarily of N-type cells
(66%) but with S-type (26%) and I-type cells (8%); S-type-
enriched populations consisted mainly of S-type cells (81%)
but also contained N-type (11%) and I-type cells (8%).
N-Type- and S-Type-Enriched Populations Respond
Differently to 9cRA Treatment and Withdrawal
N-type-enriched and S-type-enriched populations were stud-
ied over 7 days of 9cRA treatment and for a further 5 days
after removal of 9cRA. Morphological differentiation of N-
type cells, expressed as the percentage of N-type cells with at
least one neurite > 50 μm in length [6, 25–27], increased over
the course of treatment in differentiating (9cRA-treated) but
not proliferating (control-treated) N-type-enriched popula-
tions (Fig. 1a–d). S-type cells exhibit a more flattened,
spread-out morphology after 9cRA treatment [6] with an in-
crease in diameter over the course of 9cRA treatment com-
pared to proliferating S-type-enriched populations (Fig. 1g–j).
Expression of the anti-apoptotic protein Bcl-2 is up-
regulated after differentiation of neuronal SH-SY5Y cells with
retinoic acid [28] and is a useful biochemical marker of the
differentiation response to 9cRAwhich distinguishes between
N- and S-type cells [6]. There was a steady and significant
increase in Bcl-2 expression with time of 9cRA treatment in
N-type-enriched populations, although this was a slower re-
sponse than the increase in morphological differentiation (Fig.
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1e, f). Bcl-2 expression also increased, although to a lower
extent, in proliferating cells after 6 days or more in culture
(Fig. 1e). Conversely, for S-enriched populations, there was
a small effect of 9cRA in decreasing Bcl-2 expression over
time compared to proliferating control cells (Fig. 1k, l).
After 9cRA withdrawal, N-type cells reverted from a dif-
ferentiating phenotype, with a reduction in morphological dif-
ferentiation and Bcl-2 expression; conversely, S-type cells
retained a differentiated morphology and low Bcl-2 expres-
sion (Fig. 1). Thus, N- and S-type cells respond to 9cRA but
the differentiation phenotype is maintained in S-type cells but
not in N-type cells, for the latter as shown both bymorphology
and Bcl-2 expression.
Phenotype-Specific Ca2+ Store Release and Cell
Population Effects Are Evident after 9cRA-Induced
Differentiation
Ca2+ store release in response to thapsigargin was examined in
individual cells within N- and S-type-enriched populations,
treated for 7 days with 9cRA or control (Fig. 2a, b).
Analysis of single-cell data for all 5928 cells studied indicated
no significant difference overall between proliferating and dif-
ferentiating SH-SY5Y cells with respect to ER Ca2+ store
release after addition of thapsigargin (P = 0.3, Fig. 2c).
However, the effect of population type and the interaction
with differentiation status was significant, due to opposite
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effects of 9cRA treatment on N-enriched and S-type-enriched
populations, producing a decrease in the magnitude of Ca2+
store release in N-type-enriched populations but an increase in
Ca2+ store release in S-enriched population cells (P < 0.001,
Fig. 2c).
An examination of the responses of different cell pheno-
types within the N- and S-type-enriched populations revealed
cell type- and population-specific effects of differentiation on
Ca2+ store release. For N-type cells, within N-enriched popu-
lations, 9cRA-induced differentiation produced a decrease in
Ca2+ store release, but within S-enriched populations there
was an increase (Fig. 2e), suggesting an effect of the predom-
inant cell type on Ca2+ store release by N-type cells.
Conversely, for S-type cells, 9cRA differentiation had no ef-
fect on Ca2+ store release (P = 0.16) either between or within
populations. However, the level of the store release response
differed between S-type cells in the N- and S-type-enriched
populations (P < 0.001; Fig. 2e); S-type cells within N-
enriched populations had greater Ca2+ store release compared
to S-type cells within S-enriched populations, again indicating
an effect of the predominant cell type on Ca2+ store release.
I-type cells had a different profile of Ca2+ store release
response, depending on the enriched population. In N-
enriched populations, I-type cells showed an increased Ca2+
store release (P < 0.001) after 9cRA treatment, but there was
no effect of 9cRA-induced differentiation on I-type cells with-
in S-enriched populations (P > 0.6; Fig. 2e).
Total SOCE Is Altered with 9cRA-Induced
Differentiation in a Cell Population
and Phenotype-Specific Manner
After Ca2+ add-back, there was a significant decrease in
SOCE after 9cRA-induced differentiation of both N- and
S-type-enriched populations (P < 0.001; Fig. 2d). As with
Ca2+ store release, there were population- and cell
phenotype-specific differences. For N-type and S-type
cells, regardless of enrichment population, 9cRA-induced
differentiation produced a significant reduction in SOCE
(P < 0.001, Fig. 2f). However, the magnitude of these ef-
fects differed between enriched populations, with a bigger
effect of N-type cells within N-type enriched populations
compared to within S-populations, and, conversely, for S-
type cells the effect was bigger within S-enriched com-
pared to N-enriched populations (P < 0.001, Fig. 2f).
Again, this indicates an effect of population enrichment
on the Ca2+ signalling properties of individual cell types.
In marked contrast, there was no effect of 9cRA treatment
on SOCE responses of I-type cells within N-enriched pop-
ulations (P = 0.49), but a significant decrease in response
to 9cRA within S-enriched populations (P < 0.001; Fig.
2f). Total SOCE was down-regulated by 53, 60 and 63%
in N-type, S-type and I-type cells respectively, grown
within differentiating N-enriched populations, and by 68,
68 and 61%, respectively, within S-enriched populations
(Fig. 2f), and maximal SOCE was dampened after 9cRA-
induced differentiation in all cell types within both popu-
lation types (data not shown). These data demonstrate a
marked uncoupling of SOCE from thapsigargin-mediated
Ca2+ release from the ER in all cell types except I-type
cells present in SH-SY5Y cell cultures enriched for N-
type cells.
SOCE Dynamics Are Altered with 9cRA-Induced
Differentiation in a Population
and Phenotype-Specific Manner
The rates of SOCE activation and initial SOCE deactivation
were faster in proliferating and differentiating S-type-enriched
populations compared to respective N-type-enriched popula-
tions (P < 0.001, Table 1); therefore, S-type enriched popula-
tions have a more transient SOCE response than N-type-
enriched populations. For cells in both populations overall,
the rate of SOCE activation increased after 9cRA
Fig. 2 Uncoupling SOCE from ER Ca2+ store release in response to
differentiation. In cells loaded with fura-2 and in Ca2+-free buffer, chang-
es in fluorescence ratio units (FRU) reflect changes in [Ca2+]i after adding
thapsigargin (TG, 200 nM) to induce Ca2+ store release and subsequent
re-addition of extracellular Ca2+ (CaCl2, 2 mM) to induce SOCE.
Example traces from five cells combined (mean and SEM) are shown
from N-type-enriched populations (‘n’) in a, and from S-type-enriched
populations (‘s’) in b. Single-cell analysis of SOCE pathway activity
(AUC; units FRU by time in seconds, abbreviated to FRU s) in ‘n’ and
‘s’ populations treated for 7 days with 1 μM 9cRA to induce differenti-
ation or an equivalent volume of EtOH to maintain proliferation are
shown in c–f (sample sizes in Table 2). With respect to Ca2+ release for
cells within ‘n’ and ‘s’ populations overall (c), there was no significant
effect of differentiation (P = 0.3) but population and interaction effects
showed a significant decrease of Ca2+ release in cells in differentiating ‘n’
populations (P < 0.001) whereas Ca2+ release was increased in ‘s’ popu-
lations (P < 0.001). Comparisons of N-type cells within and between
populations (e) showed that all main effects and interactions were signif-
icant: there was a significant decrease of Ca2+ release in N-type cells
within ‘n’ populations but a significant increase of Ca2+ release in N-
type cells within ‘s’ populations (P < 0.001). For S-type cells, there was
no significant effect of differentiation (P = 0.16), or interaction, but a
significant difference between populations (P < 0.001). All effects for I-
type cells (population, differentiation) were significant (P < 0.001 for dif-
ferentiation; P < 0.01 for population and interactions), but from the inter-
action effects, there was no difference in Ca2+ release as a result of dif-
ferentiation of I-type cells within ‘s’ populations (P > 0.6) in contrast to
the increased Ca2+ release after differentiation of I-type cells within ‘n’
populations (P < 0.001). For SOCE data for all cell types within popula-
tions (d), there was a significant effect of differentiation on reducing
SOCE in both populations (P < 0.001), and this was also the case for N-
type and S-type cells separately (f), although S-type cells had a bigger
reduction of SOCE in ‘s’ populations (P < 0.001). For I-type cells, SOCE
was significantly reduced by differentiation within ‘s’ populations (P <
0.001), a consequence of the high SOCE response of I-type cells in
proliferating ‘s’ populations compared to proliferating ‘n’ populations.
All error bars are ± SEM
R
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differentiation (P < 0.05, Table 1). Individual N-type, S-type
and I-type cells within S-enriched populations also had a more
transient SOCE response as a result of higher rates of SOCE
activation and initial deactivation compared to those cell types
within N-enriched populations (P < 0.001, Table 2).
The effects of differentiation with 9cRA on the dynamics
of SOCE responses of different cell types varied between N-
and S-enriched populations. For N-type cells, the SOCE re-
sponse was more transient within N-enriched populations
compared to N-type cells in S-enriched populations where
the initial rates of deactivation did not increase after differen-
tiation (Table 2). In contrast, for S-type cells within both pop-
ulations, the SOCE response was less transient after differen-
tiation, but the magnitude of this effect was bigger for S-type
cells within S-enriched populations. Finally, for I-type cells
the SOCE response was more transient in N-enriched popula-
tions after differentiation as a result of increases in rates of
activation and initial deactivation, but within S-enriched pop-
ulations, I-type cells had decreased initial rates of SOCE de-
activation which may have counteracted the increased rates of
activation in response to 9cRA (Table 2). Thus, there are
population-specific and cell phenotype-specific effects of
9cRA on the dynamics of SOCE.
Orai1 Is Down-Regulated and STIM1 Is Relocalised
in Differentiating Cell Populations
Orai1 forms the PM CRAC channel pore and is required for
cytosolic Ca2+ entry to replenish depleted ER Ca2+ stores
[29–31]. Orai1 was expressed by proliferating and differenti-
ating N-type-enriched and S-type-enriched populations
(Fig. 3a) and, compared to proliferating populations, was sig-
nificantly down-regulated by 52–54% in differentiating pop-
ulations regardless of phenotype (ANOVA, P = 0.001, Fig.
3a), consistent with the extent of SOCE reduction (Fig. 2c).
Furthermore, CRAC inhibition by BTP-2 in both N-type-
enriched and S-type-enriched populations substantially sup-
pressed SOCE activity (Fig. 3c) which is consistent with the
role of Orai1 in SOCE within N-type-enriched and S-type-
enriched populations [6].
The Ca2+-sensing protein STIM1 alters gating of PM
CRAC channels through direct interaction with Orai1 to
Table 1 Rates of SOCE
activation and initial deactivation
for cells in N-type- and S-type-
enriched populations (± SEM)
Population Status SOCE activation
rate (FRU s−1)
Initial SOCE deactivation
rate (FRU s−1)
N-type enriched Proliferating 49.4 ± 1.9 6.58 ± 0.181
N-type enriched Differentiating 56.7 ± 1.7 7.37 ± 0.15
S-type enriched Proliferating 87.0 ± 2.25 11.63 ± 0.212
S-type enriched Differentiating 98.6 ± 3.54 9.66 ± 0.235
Table 2 Rates of SOCE
activation and initial deactivation
for individual cell types (N, S and
I) in N-type- and S-type-enriched
populations (± SEM). Sample
sizes for N-type-enriched
populations were 1204 proliferat-
ing (control) cells (761 N-, 307
S- and 136 I-type) and 1456
differentiating cells (1080 N-, 264
S- and 112 I-type). For S-type-
enriched populations, there were
1897 proliferating (control) cells
(679 N-, 1029 S- and 189 I-type)
and 1371 differentiating cells
(449 N-, 669 S- and 442 I-type)
Population Status SOCE activation
rate (FRU s−1)
Initial SOCE deactivation
rate (FRU s−1)
N-type cells
N-type enriched Proliferating 45.2 ± 1.8 6.0 ± 0.202
N-type enriched Differentiating 54.0 ± 1.98 7.16 ± 0.167
S-type enriched Proliferating 89.4 ± 4.14 12.2 ± 0.354
S-type enriched Differentiating 116.3 ± 6.92 12.18 ± 0.445
S-type cells
N-type enriched Proliferating 59.3 ± 5.1 7.83 ± 0.394
N-type enriched Differentiating 57.3 ± 3.37 6.95 ± 0.266
S-type enriched Proliferating 86.25 ± 2.96 10.7 ± 0.27
S-type enriched Differentiating 81.4 ± 4.29 7.54 ± 0.264
I-type cells
N-type enriched Proliferating 53.1 ± 9.08 7.56 ± 0.745
N-type enriched Differentiating 79.8 ± 7.45 10.2 ± 0.798
S-type enriched Proliferating 81.9 ± 5.05 14.4 ± 0.804
S-type enriched Differentiating 109.04 ± 8.54 10.3 ± 0.586
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induce Ca2+ entry and replenish depleted ER Ca2+ stores [15,
18, 32]. STIM1 was expressed by N-type-enriched and S-
type-enriched populations in proliferating and differentiating
conditions, but to higher levels in S-type-enriched populations
(ANOVA, P = 0.004; Fig. 3b). The apparent reduction of
STIM1 expression in 9cRA-differentiated cells of both popu-
lations was not statistically significant, but of possible biolog-
ical interest given the low P value (ANOVA, differentiation,
P = 0.075; differentiation/population interaction, P = 0.63)
and time-course data (Fig. 4).
There was evidence of a change in localisation of STIM1
after 9cRA-induced differentiation, and clear differences in
localisation between N-type and S-type cells. In resting pro-
liferating N-type cells, STIM1 was expressed uniformly with
some evidence of foci (Fig. 3d, e). Upon differentiation,
STIM1 expression became less evenly distributed and dis-
tinctly clustered (Fig. 3d), as quantified by measurements of
linear profile immunofluorescence pixel intensity (Fig. 3e (a–
c)). STIM1 was expressed throughout resting proliferating
and differentiating S-type cells with an abundance of STIM1
close to the nucleus (Fig. 3d, f); however, there were clear
examples of differentiating S-type cells with an accumulation
of STIM1 at the PM (Fig. 3d, f). There was an increase in the
range of STIM1 fluorescence intensity as well as higher fluo-
rescence intensities in differentiating compared to proliferat-
ing N-type and S-type cells (Fig. 3e (d), f (d)), reflecting the
accumulation of STIM1 into cytoplasmic clusters in differen-
tiating N-type cells and at the PM of differentiating S-type
cells.
Remodelling of SOCE in Cell Populations Is Associated
with Initiation and Maintenance of the Differentiated
Phenotype
To understand the relationship between SOCE uncoupling
and the differentiation response, we investigated the time
course of changes in SOCE activity and SOCE protein
expression after addition of 9cRA to N-type-enriched
and S-type-enriched populations. SOCE was recorded in
individual cells, and data, representing two to five exper-
iments per day for 1–7 days of treatment with 9cRA, were
analysed in relation to N-type and S-type cells within N-
enriched and S-enriched populations; the number of I-type
cells measured per time point was too small for meaning-
ful analysis. Compared to proliferating N-type-enriched
populations, within 24 h of 9cRA treatment, total SOCE
was down-regulated by > 40% (Fig. 4a) in differentiating
N-type-enriched populations, with an apparently greater
response in S-type cells (P < 0.01; Fig. 4a) and a gradual
decline over a 7-day period. This SOCE response coin-
cided with a 50% down-regulation of STIM1 expression
(Fig. 4c, e), a 75% down-regulation of Orai1 expression
(Fig. 4c, g) and morphological differentiation (Fig. 1).
These results suggest that 9cRA-induced differentiation
of N-type-enriched populations induces an uncoupling of
SOCE from ER Ca2+ store release within the first day of
treatment. After treatment withdrawal for 5 days, total
SOCE returned to that of proliferating cells (Fig. 4a), in
accordance with the loss of biochemical differentiation
(Fig. 1e, f). Whilst STIM1 levels were similar in prolifer-
ating and differentiating cells after treatment withdrawal,
in the 9cRA-treated cells there was evidence from the
Western blots of an increase in apparent molecular weight
of STIM1 and Orai1 levels remained low (Fig. 4c, g).
In S-type-enriched populations, within 24 h of 9cRA
treatment, there was also a substantial down-regulation of
total SOCE, and to a greater extent in S-type cells com-
pared to N-type cells (P < 0.01; Fig. 4b). STIM1 and
Orai1 expression was also decreased in differentiating
cells (Fig. 4d, f, h). The extent of SOCE activity down-
regulation gradually increased with time of treatment (Fig.
4b). After treatment withdrawal, total SOCE in N-type
cells within differentiated S-type-enriched populations re-
covered and was not significantly different from that of
proliferating S-enriched populations (P > 0.05, Fig. 4b).
Conversely, for S-type cells within S-type-enriched popu-
lations, SOCE remained depressed after 9cRA withdrawal
compared to proliferating cells (Fig. 4b). Orai1 expression
also remained down-regulated compared to proliferating
populations (Fig. 4d, h). As with N-type-enriched popu-
lations, there was similar evidence of an increase in
STIM1 molecular weight after 9cRA withdrawal (Fig.
4d). Overall, these data mirror the changes in cell mor-
phology (Fig. 1) where S-type cells remained differentiat-
ed despite withdrawal of 9cRA, and suggest a link be-
tween SOCE responses and the differentiation status of
N- and S-type cells.
The changes in SOCE in response to differentiation
were also accompanied by changes in SOCE kinetics
(Fig. 5). For cells in N-type-enriched and S-type-
enriched populations, 9cRA treatment increased SOCE
activation and deactivation rates (P < 0.01), with differen-
tiation having greater effects on N-type cells in both pop-
ulations (P < 0.001), except for activation rates in S-
enriched populations where the difference between N-
and S-type cells was marginal, P = 0.09). Overall, both
cell types responded in similar ways (P > 0.04), except
that SOCE initial deactivation rates were lower for S-
type cells in S-type-enriched populations (P < 0.001, Fig.
5d). After washout, SOCE activation and initial deactiva-
tion rates remained elevated in differentiating N-type cells
regardless of population, and in differentiating S-type
cells in N-type-enriched populations, whereas in S-type-
enriched populations, SOCE activation and initial deacti-
vation rates of differentiating S-type cells were more sim-
ilar to proliferating cells (Fig. 5).
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Discussion
Previous findings from this laboratory have shown that SOCE
becomes down-regulated in mixed [22] and enriched [6] pop-
ulations of 9cRA-differentiated SH-SY5Y neuroblastoma
cells. In this study, we have used single-cell analysis to char-
acterise SOCE remodelling in differentiating N-type, S-type
and I-type SH-SY5Y cells to determine how the remodelling
response of the cell phenotypes influences that of the SH-
SY5Y cell population as a whole. Our work reveals a
Mol Neurobiol
surprising finding that Ca2+ signal remodelling in differentiat-
ing SH-SY5Y cells is independent of morphological pheno-
type but is apparently modulated by the cellular environment.
SH-SY5Y populations enriched for N-type or S-type
cells both differentiated morphologically in response to
9cRA, but in a dissimilar manner with respect to cell
shape, timing and Bcl-2 expression. In addition, Ca2+
signals were remodelled in both populations, but with
different characteristics with respect to Ca2+ release and
SOCE. Upon withdrawal of differentiating agent, N-type
cells showed morphological and biochemical ‘de-differen-
tiation’, whereas S-type cells retained a morphologically
and biochemically differentiating phenotype. The cell
types therefore differ in their phenotypic stability; N-
type (neuronal) cells are phenotypically labile, whilst S-
type (glial) cells are phenotypically stable.
In both cell populations, differentiation-induced Ca2+ sig-
nal remodelling included down-regulation of SOCE responses
and Orai1 expression. Interestingly, the remodelled differenti-
ating N-type phenotype was not fully restored when N-type
populations were de-differentiated, since SOCE returned to
pre-differentiation levels whilst Orai1 expression remained
depressed. One possibility is that de-differentiation of N-
type cells involves remodelling of the CRAC channel from
Orai1 to Orai2 and/or Orai3 [33–35]. In support of this, de-
differentiated N-type cells had higher rates of SOCE activa-
tion and initial SOCE deactivation (Fig. 5). This is consistent
with studies showing that heterologously expressed Orai2 and
Orai3 conduct CRAC-like currents with distinct biophysical
characteristics from Orai1, including different activation and
inactivation kinetics [34, 36].
STIM1 was also remodelled in a cell phenotype-dependent
manner in differentiating SH-SY-5Y cells: both STIM1 ex-
pression and localisation were altered in N- and S-type cells.
There was evidence of a slight increase in STIM1 molecular
weight with 9cRA-induced differentiation of both phenotypes
that was more apparent after 9cRAwithdrawal. Given that this
coincided with a relocalisation of STIM1 in both cell types,
there may be a post-translational modification or shift in pre-
dominant isoform of STIM1 with differentiation. One possi-
bility is up-regulation of the longer spliced variant, STIM1L
[37, 38]. STIM1L has been proposed to form permanent clus-
ters which allow the immediate activation of SOCE [37]. This
would be consistent with the appearance of STIM1 clusters in
differentiating N-type cells and the increased SOCE activation
rates observed in differentiating cells.
In addition to the remodelling of SOCE, 9cRA-induced
differentiation also resulted in the remodelling of TG-
induced Ca2+ release in both cell types: in N-type populations,
there was a decrease in Ca2+ store release whilst in S-type
populations there was an increase. To investigate how remod-
elling of the population Ca2+ response is influenced by the
predominant cell phenotype, we examined responses of dif-
ferent cell phenotypes within N- and S-type-enriched popula-
tions. For N-type cells within N-type-enriched populations,
9cRA treatment resulted in a decrease in TG-induced Ca2+
release. However, for N-type cells within S-type-enriched
populations, 9cRA treatment resulted in an increase in Ca2+
store release. This suggests an effect of the predominant cell
type on Ca2+ store release by N-type cells. Similarly, S-type
Fig. 3 Altered expression of Orai1 and STIM1 and relocalisation of
STIM1 in relation to 9cRA-induced differentiation of N-type- and S-
type-enriched populations. N- (‘n’) and S-type-enriched (‘s’) populations
were treated for 7 days with 1μM9cRA to induce differentiation (DN and
DS respectively) or control vehicle to maintain proliferation (PN and PS
respectively) and analysed for Orai1 (a) and STIM1 (b) expression by
densitometry of Western blots using β-actin as a loading control. Orai1
expression, relative to β-actin, did not differ between populations (linear
model ANOVA, F1,29 < 0.35, P > 0.5 for main effect and interaction) but
was significantly reduced in expression by differentiation in both ‘n’ and
‘s’ populations (F1,29 = 13.1, P = 0.001). In contrast, STIM1 was
expressed to a higher level overall in ‘s’ populations (ANOVA, F1,58 =
9, P < 0.01), but there was only a marginal effect of differentiation on
both populations (differentiation F1,58 = 3.3, P = 0.075; interaction
F1,58 = 0.23, P > 0.6). Cell populations were treated for 24 h with the
CRAC-channel inhibitor BTP2 (c) at doses ranging from 0.1 to 20 μM
and Ca2+ release in response to thapsigargin and SOCE analysed at a
single-cell level within populations and between cell types within
enriched populations. BTP2 at all doses (only 0.1 and 0.2 μM shown as
no further reduction with increasing dose) did not affect thapsigargin-
induced Ca2+ release but significantly reduced SOCE to similar extents
in ‘n’ and ‘s’ populations (background corrected [no thapsigargin, by
experiment, BTP2 dose, population and cell type]; ANOVA, effect of
BTP2: F1,3761/3463 > 47, P < 0.001), with no differences between N-, S-
and I-type cells within each population (F2,3761 = 2.1, P = 0.12, and
F2,3463 = 0.92, P = 0.4 for ‘n’ and ‘s’ populations, respectively). Total
Ca2+ entry shows AUC (units FRU by time in seconds, abbreviated to
FRU s) of fluorescence traces after activation of SOCE by readdition of
extracellular Ca2+. In PN cells, STIM1 was present throughout the cyto-
plasm and neurite-like processes, with some evidence of localisation into
foci (d (a) white arrows) whilst in DN cells STIM1 formed distinct clus-
ters (d (b) white arrows). In ‘s’ populations, STIM1 was present through-
out PS cells (d (c)) with no apparent clustering whilst in DS cells there
were clear examples of cells with an accumulation of STIM1 at the PM (d
(d), dashed arrows). Scale bars represent 20 μm. The distribution of
STIM1 was measured across the length of a proliferating and differenti-
ated cell within an ‘n’ population (e (a) and e (b), respectively), and within
an ‘s’ population (f (a) and f (b), respectively), as shown by dashed
straight lines. The linear profile immunofluorescence pixel intensity over
the distance of the cell bodies shown was quantified. STIM1 expression
was distributed relatively evenly across PN cells with evidence of some
STIM1 foci in the cytoplasm (*) whereas in the cytoplasm of DN cells
STIM1 expression was less evenly distributed and instead formed distinct
clusters (*) (e (c)). For ‘s’ populations, STIM1 expression was greatest in
cytoplasmic regions close to the nucleus of PS cells (*), and there was an
accumulation of STIM1 at the membrane (*) and close to the nucleus of
DS cells (f (c)). Scale bars represent 5 μm (e (a, b), f (a)) or 10 μm (f (b)).
There was an increased range of fluorescence intensities with highest
pixel intensities in differentiating cells compared to proliferating cells (e
(d) and f (d)). In ‘n’ populations, a shift in the number of low (PN) to high
(DN) intensity pixels is consistent with differentiation-induced clustering
of STIM1 (e (d)). Single-cell images (e, f) are representative of PN n =
125, DN = 125, PS = 129, DS = 128 fromN ≥ 4, with ≥ 3 fields of view and
≥ 15 cells per experiment
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cells within N-type-enriched populations had greater Ca2+
store release compared to S-type cells within S-type-
enriched populations, again indicating an effect of the pre-
dominant cell type of Ca2+ store release. The reduction in
Ca2+ store release after differentiation of N-type populations
is entirely consistent with greater lability of the Ca2+ store
reported previously in these cells [39], and this remodelling
could contribute to the reduced stability of the differentiating
N-phenotype compared with the differentiating S-phenotype
reported here. For differentiating I-type cells also, the
remodelled Ca2+ release response was dependent upon the
enriched population. Interestingly, the remodelled SOCE re-
sponse of differentiating I-type cells was dependent upon the
enriched population, whereas the remodelled SOCE response
of differentiating S-type and N-type cells was not (i.e. SOCE
was down-regulated in differentiating S-type and N-type cells,
irrespective of cellular context, whereas in I-type cells, SOCE
was only down-regulated within S-type-enriched
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populations). This observation suggests that I-type cells have
the greatest potential of all the cell phenotypes for remodelling
their Ca2+ responses.
The SH-SY5Y neuroblastoma cell line has been used for
many years as a model for elucidating signalling mechanisms
in neurogenesis [3, 40] and disease [2, 41–44]. The finding
that Ca2+ signalling is remodelled in both differentiating N-
type and S-type cells, but with different characteristics with
respect to Ca2+ release and SOCE, supports the idea that these
phenotypes represent distinct lineages of neuronal (N-type)
and glial (S-type) cells. Furthermore, the changes in biophys-
ical characteristics of Ca2+ signals (e.g. extent of Ca2+ store
release, SOCE activation and inactivation rates) that accom-
pany differentiation concurs with evidence that different iso-
forms of STIM and Orai proteins predominate in neurons and
glial cells [33, 35, 45]. This reinforces the idea that STIM and
Orai isoforms could represent possible drug targets for the
treatment of neuronal or glial dysfunction that may underlie
neurodegenerative disorders.
In addition, the results of the present study also emphasise
the importance of Ca2+ channels in cancer, particularly the
regulation of interactions between different tumour compo-
nents and implications for cell phenotype and tumorigenicity.
The greater stability of the differentiating phenotype of S-type
cells reported here concurs with the lower malignant potential
of S-type neuroblastoma cells compared to N-type cells [46].
Critically, I-type cells may have the greatest malignant poten-
tial [47], and the greater potential of I-type cells to remodel
their Ca2+ responses is a new dimension with substantial clin-
ical and therapeutic implications. The different SOCE proper-
ties of I-type cells in N-type-enriched populations provide
validation of the morphological criteria used as the basis of
cell classification. However, although the properties of these I-
type cells may reflect a characteristic of the N-type-enriched
environment, these I-type cells may also be mechanically dis-
tinct from I-type cells in S-type-enriched populations; one
possibility is that these are I-type cells detached easily by
virtue of cell cycle stage and with SOCE properties influenced
by their environment. Alternatively, I-type cells with different
substrate-adherent properties may be more immediate progen-
itors of N-type and S-type cells, respectively, representing an
intermediate phenotypic stage in conversion from I-type to N-
or S-type, or may represent distinct lineage-restricted precur-
sors to these phenotypes that have hitherto been unrecognised.
Addressing these questions will demand different experimen-
tal approaches to elucidate the lineage and phenotypic charac-
teristics of I-type cells.
This study also raises the question of the role of Ca2+ sig-
nalling mechanisms in neuroblastoma cell survival. We have
previously shown that neuroblastoma cells respond to RA-
induced differentiation by induction of an arachidonic acid
(AA)-mediated survival mechanism [48]. Since these cells
also show up-regulation of a non-SOCE and non-voltage-
dependent Ca2+ entry pathway [22], one possibility is that an
up-regulated arachidonate-regulated Ca2+ (ARC) entry path-
way may have a role in cell survival. However, since Orai1
and STIM1 are involved in ARC as well as in SOCE [49], and
the down-regulation of one of more of these components [50]
or proteins that interact with them [51, 52] may protect tumour
cells from apoptosis, dynamic modelling approaches are need-
ed to clarify how such signalling processes interact in the
context of cell differentiation and tumour biology.
The mechanism by which Ca2+ signal remodelling in dif-
ferentiated cell phenotypes is modulated by the surrounding
cellular environment is unknown. However, the finding is
reminiscent of the bystander effect in cellular senescence
[53] in that senescent cells spread senescence towards their
neighbours by producing and secreting bioactive molecules
[54, 55] or via gap junction-mediated cell-cell contact [53].
Although cellular senescence and terminal differentiation are
distinct physiological process [56], it is noteworthy that both
are forms of proliferative control that involve essentially
Fig. 4 Time course of changes in SOCE in N-type-enriched (‘n’) and S-
type-enriched (‘s’) populations in relation to differentiation and changes
in expression of STIM1 and Orai1. N-type (left column) and S-type (right
column) populations were treated for up to 7 days with 1 μM 9cRA (DN
and DS, respectively) to induce differentiation or control vehicle to main-
tain proliferation (PN and PS, respectively); treatment was subsequently
withdrawn and cells grown in standard culturemedium for a further 5 days
(WD). For the analysis of changes in SOCE at the single-cell level for N-
type and S-type cells within ‘n’ (a) and ‘s’ (b) populations, all data were
corrected for background calcium in the absence of thapsigargin. Data for
SOCE of differentiating cells were expressed as a proportion of SOCE in
proliferating cells at the relevant time point, normalised by Box-Cox
transformation and analysed using linear mixed-effects models with ex-
periment and coverslip within experiment as random effects. P values for
ANOVAwere obtained by simulation. SOCEwas rapidly down-regulated
by differentiation in both populations and cell types within populations
and continued to decrease over 7 days (P < 0.001). For ‘n’ populations
(a), there was no significant difference between N-type and S-type cells
(P > 0.9), but for ‘s’ populations (b) reduction in SOCE was significantly
lower for S-type cells than for N-type cells (P < 0.001). After washout in
both population types, SOCE of N-type cells returned to values similar to
proliferating cells, but SOCE of S-type cells remained depressed.
Densitometry of Western blots (c, d) was used to examine the expression
of STIM1 (e, f) andOrai1 (g, h) in ‘n’ (c, e, g) and ‘s’ (d, f, h) populations.
For STIM1 expression in ‘n’ populations (e), there was a small but sig-
nificant reduction in response to differentiation compared to proliferating
cultures (first-order linear additive mixed-effects model, P < 0.001), but
no significant change with time of culture (P = 0.8). Similarly, for ‘s’
populations, there was a small reduction of STIM1 expression in differ-
entiated cells (P = 0.025), and no significant effect of time in culture (P =
0.9). For Orai1 expression, second-order linear mixed-effects models
gave a better fit to the data, with differentiation significantly reducing
Orai1 expression compared to proliferating cultures in both ‘n’ and ‘s’
populations (P < 0.001), a difference that was maintained after washout
(g, h). In the case of ‘s’ populations, the data suggest a significant decline
with time in culture (orthogonal polynomial linear term, P < 0.01 for ‘s’
populations; no effect of time in ‘n’ populations, P > 0.1). All error bars
are ± SEM
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permanent exit from the cell cycle [57]. A stress-induced by-
stander effect in neuronal stem progenitor cells induced by
glioblastoma and medulloblastoma cells has been reported
[58]; however, the present results raise the possibility that
the effect is also seen in normal, unstressed neuronal cells.
Enrichment of neuronal tumours with a specific cell type
may affect the magnitude of the bystander effect that they
may exert.
In summary, these results demonstrate the unique biology of
neuronal and glial derivatives of common precursors and re-
veals the complexity of Ca2+ signal remodelling, particularly in
relation to potential reciprocal interactions between survival via
ARC/arachidonate-mediated Ca2+ signalling and SOCE in
remodelled differentiated cells. This study also shows that di-
rect or indirect interactions between cell types are important
modulators of signalling processes in relation to neurogenesis.
This requires detailed assessment in experimental models. Our
results also highlight that the many studies using neuroblasto-
ma derivatives as experimental models need to take account of
how cellular heterogeneity could be influenced by culture tech-
niques, as well as impact upon conclusions drawn from the
tested population, and report these accordingly.
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